Health
Baricitinib treatment linked to reduced mortality in COVID-19 patients – Medical Xpress
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research…
The rheumatoid arthritis drug baricitinib can block viral entry and reduce mortality in patients with moderate to severe COVID-19, according to translational research by an international team coordinated by researchers from Karolinska Institutet in Sweden. The findings, published in the journal Science Advances, support the continuation of ongoing randomized clinical trials.
“We are pleased to report a 71 percent reduction in mortality for the group receiving baricitinib in addition to standard…
-
Noosa News21 hours agoTeen killed in single-vehicle accident in Coolabunia, South Burnett, Queensland
-
General23 hours agoLiberal Lee Jae-myung projected to win South Korea’s snap presidential election
-
General21 hours agoTelstra fined for disruption to emergency call service used by people with hearing, speech impairments
-
General22 hours agoFoundational Liberal values | The Spectator Australia